2025 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2025: 5 approvals, 65 patent expiries, 0 Phase 3 milestones.

20232024202520262027

FDA / EMA / MHRA approvals (5)

Patent expiries (65)

Phase 3 readouts (0)

No entries tracked.